Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention
NCT04572750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2026-01-23
Summary
Benzodiazepines (e.g., Ativan, Xanax) are widely prescribed medications that are used mainly to treat anxiety and sleeping difficulties. Long-term use of benzodiazepine carries risks of physical dependence, addiction, falls and other accidents, and problems in thinking/concentrating. Researchers in Canada developed a printed self-help packet that enabled many individuals to reduce or cease taking benzodiazepines on their own. This study is designed to tailor that packet to the Veteran population, convert it to an app that people can use on their laptop or smart phone, and test whether the app helps promote benzodiazepine prescribing.
Conditions
- Taking Benzodiazepines for Any Reason for 3 Months
- Benzodiazepine Dependence
Interventions
- BEHAVIORAL
-
EMPOWER-ED
An electronic app that runs on a variety of platforms and provides education and tools designed to promote self-driven reduction of benzodiazepines.
Sponsors & Collaborators
-
VA Office of Research and Development
lead FED
Principal Investigators
-
Keith N. Humphreys, PhD MA · VA Palo Alto Health Care System, Palo Alto, CA
-
Michael A Cucciare, PhD · Central Arkansas Veterans Healthcare System , Little Rock, AR
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2024-07-03
- Completion
- 2024-07-03
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Alcohol Withdrawal in Hospital Patients
NCT00249366 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Valproate on Benzodiazepine Withdrawal Severity
NCT00570219 ·Status: COMPLETED ·Phase: NA
-
Can Connected Devices Increase the Success Rate of Benzodiazepine Withdrawals in the Elderly?
NCT04912479 ·Status: RECRUITING ·Phase: NA
-
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
NCT00523185 ·Status: COMPLETED ·Phase: NA
-
Drug Therapy for Alcohol Detoxification
NCT00000441 ·Status: COMPLETED ·Phase: PHASE4
-
GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1
NCT00123578 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Treating Alcohol Withdrawal With Oral Baclofen
NCT00597701 ·Status: COMPLETED ·Phase: NA
-
Fixed-schedule Benzodiazepine Dosing vs Based on a CIWA-Ar Alcohol Protocol in Alcohol Detoxification.
NCT04777552 ·Status: COMPLETED
-
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
NCT01342549 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
NCT05438641 ·Status: COMPLETED
-
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal
NCT01573052 ·Status: COMPLETED ·Phase: PHASE4
-
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
NCT03586089 ·Status: TERMINATED ·Phase: NA
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Transdermal Clonidine in Trauma Patients
NCT01139996 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
NCT01652326 ·Status: COMPLETED
-
GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence
NCT00611767 ·Status: COMPLETED ·Phase: NA
-
Remote Treatment of Alcohol Withdrawal
NCT04858490 ·Status: COMPLETED ·Phase: NA
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
NCT02823977 ·Status: WITHDRAWN ·Phase: PHASE4
-
Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder
NCT05226130 ·Status: COMPLETED ·Phase: PHASE1
-
Gabapentin for Alcohol Withdrawal Syndrome
NCT03012815 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
NCT00229125 ·Status: COMPLETED ·Phase: PHASE2
-
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
NCT01204255 ·Status: COMPLETED ·Phase: NA
-
Reducing Concurrent Opioid-Benzodiazepine Prescriptions
NCT03887247 ·Status: UNKNOWN ·Phase: NA
-
Baclofen in Managing Acute Alcohol Withdrawal
NCT03293017 ·Status: UNKNOWN ·Phase: PHASE4